MaxCyte, Inc. (NASDAQ:MXCT – Get Rating)’s share price traded up 8.1% during mid-day trading on Monday . The stock traded as high as $4.98 and last traded at $4.92. 341,938 shares changed hands during trading, a decline of 36% from the average session volume of 534,032 shares. The stock had previously closed at $4.55. Wall […]
MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) shares were up 5.4% on Tuesday . The stock traded as high as $5.07 and last traded at $5.05. Approximately 240,222 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 569,156 shares. The stock had previously closed at $4.79. Wall Street Analyst […]
MaxCyte, Inc. (NASDAQ:MXCT – Get Rating) Director Richard Douglas acquired 80,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 29th. The stock was bought at an average price of $4.32 per share, with a total value of $345,600.00. Following the transaction, the director now directly owns 100,000 shares in the […]